EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Propolis Supplementation in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Ting-An Kuo, Ji-Yao Lai iD, Kuo-Chih Tseng, Made Satya Nugraha Gautama iD, Tsai-Wei Huang iD

Phytotherapy Research · 2026-11-10

DOI: 10.1002/ptr.70512 ↗

At a glance

Systematische Übersicht in Phytotherapy Research, published online on 2026-11-10. Written by Ting-An Kuo and 4 co-authors. Institution: School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. 31 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects 38% of adults globally, with limited pharmacotherapy. Propolis, a bee‐derived compound with diverse biological activities, has emerged as a potential adjunct therapy. This systematic review and meta‐analysis evaluated the effects of propolis supplementation on hepatic steatosis, metabolic parameters, and liver function in adults with MASLD. We searched PubMed, Embase, and Cochrane Library from inception to December 2025 without language or publication‐status restrictions and included randomized controlled trials comparing propolis with placebo or dietary counseling in adults with MASLD or nonalcoholic fatty liver disease (NAFLD). Two reviewers independently screened studies, extracted data, and assessed risk of bias with the Cochrane ROB 2.0 tool. Meta‐analyses used random‐effects models. Publication bias was assessed with Doi plots and the Luis Furuya‐Kanamori (LFK) index, and certainty of evidence with the GRADE approach. Four trials ( n = 178) of Iranian poplar‐type propolis were included. Propolis was associated with significant improvement in hepatic steatosis (three trials, n = 156; RR: 2.41; 95% CI: 1.59–3.66; p < 0.001; I 2 = 0%) and modestly reduced fasting glucose (MD: −3.80 mg/dL; p = 0.018). No significant effects were observed on insulin sensitivity indices, lipid profiles, anthropometric measures, or liver enzymes. No publication asymmetry was detected (LFK index = 0.82). Exploratory single‐study CYP2E1 and TRPV4 signals were non‐significant for propolis monotherapy versus control and confounded by exercise co‐intervention. In a small number of short‐term trials, propolis supplementation was associated with improvement in ultrasound‐assessed hepatic steatosis, with low heterogeneity. However, limited trials, small samples, restriction to Iranian propolis, absence of histological endpoints, and single‐study mechanistic findings position this as hypothesis‐generating research. GRADE certainty was very low to low, underscoring the need for larger, well‐designed trials.

Subjects

Author keywords

MASLDhepatic steatosismetabolic dysfunction‐associated steatotic liver diseasepropolissystematic review and meta‐analysis

Authors and institutions

  • School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • School of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Department of Medical Education, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan.
  • School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Department of Nursing, Faculty of Medicine, Universitas Pendidikan Ganesha, Singaraja, Indonesia.

ORCID profiles: Ji-Yao Lai, Made Satya Nugraha Gautama, Tsai-Wei Huang

Cite

APA

Kuo, T. A., Lai, J. Y., Tseng, K. C., Gautama, M. S. N., & Huang, T. W. (2026). Propolis Supplementation in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Phytotherapy Research. https://doi.org/10.1002/ptr.70512

Vancouver

Kuo TA, Lai JY, Tseng KC, Gautama MSN, Huang TW. Propolis Supplementation in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Phytotherapy Research. 2026. doi:10.1002/ptr.70512

BibTeX
@article{Kuo2026,
  author = {Kuo, Ting-An and Lai, Ji-Yao and Tseng, Kuo-Chih and Gautama, Made Satya Nugraha and Huang, Tsai-Wei},
  title = {Propolis Supplementation in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70512}
}
Start for free →